评估阿司匹林的间歇剂量对于结肠直肠癌的化学预防
Xiangzhu Zhu1, Ruohui Chen2, Reid M Ness3
1Vanderbilt University, Nashville, TN, United States.
Cancer prevention research (Philadelphia, Pa.)
|March 4, 2025
概括
连续每日服用阿司匹林在减少结肠直肠癌生物标志物方面比间歇剂量更有效. 需要进一步的研究,以优化阿司匹林的时间表,以预防癌症,并尽量减少副作用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 已知阿司匹林可降低结肠直肠癌的风险,但可能导致不良影响.
- 临床前研究表明,间歇性阿司匹林剂量可以减少副作用,同时保持疗效.
- 了解最佳的阿司匹林剂量对于预防结直肠癌至关重要.
研究的目的:
- 为了比较连续每日阿司匹林与间歇性阿司匹林 (3周/3周休息) 在结肠直肠癌生物标志物的疗效.
- 评估不同阿司匹林剂量表的安全性和耐受性.
- 评估阿司匹林对直肠粘膜中的生物标志物的影响.
主要方法:
- 一个三臂,双盲,随机,安慰剂控制的II期试验.
- 81名参与者被随机分配,其中45名可评估.
- 分析了与直肠粘膜中的结直肠癌发生相关的生物标志物.
主要成果:
- 对于主要终点 (Ki-67:BCL2相关的X比率) 连续和间歇性阿司匹林之间的等价性没有确立.
- 与间歇剂量相比,连续用阿司匹林显著降低了Ki-67:终端脱氧核胺转移酶介导的dUTP末标记比率.
- 连续用阿司匹林显示出比间歇性阿司匹林更大程度地降低了上皮的COX-2表达.
结论:
- 间歇性阿司匹林剂量 (3周/3周休息) 不产生与持续剂量对结直肠癌生物标志物的生物效应相同的生物效应.
- 持续服用阿司匹林似乎更有效地减少关键生物标志物.
- 未来的研究应该探索其他间歇性时间表,如1周休息/1周休息,以平衡疗效和安全.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
116
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
116
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Peptic Ulcer Disease IV: Management
58
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
58
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Drugs for Treatment of Diarrhea-Predominant IBS
139
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
139
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.8K


